You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
維亞生物(01873.HK)續漲近9%擬回購最多1.5億股
阿思達克 07-12 11:11

維亞生物(01873.HK)建議於合適時間在公開市場回購最多1.5億股(相當於股本10%),該股七連升,最高4.22元,創近個半月高,現造4.17元,續升8.9%,一向薄弱成交倍增至469萬股,涉資1,933萬元。

維亞生物科技主要經營一個領先基於結構新藥發現技術平台。股份於今年5月9日以每股4.41元上市,股價於5月15日升至5.45元無以為繼,掉頭反覆回落,6月25日低見3.15元獲承接。

維亞生物公布,擬根據4月中旬股東通過書面決議案所授權回購公司股份,於合適時間在公開市場回購最多1.5億股(相當於股本10%)。董事會認為現價未能反映其內在價值,為公司回購股份良機,相信透過回購可提升股份價值,從而改善股東回報。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account